id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-254717-1hwdd7nq	Al-Tawfiq, Jaffar A.	Remdesivir as a possible therapeutic option for the COVID-19	2020-03-05		.txt	text/plain	902	37	44	MERS-CoV as an emerging respiratory illness: a review of prevention methods Situation Report-17 SITUATION IN NUMBERS total and new cases in last 24 hours Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys Nucleotide prodrug GS-5734 is a broad-spectrum filovirus inhibitor that provides complete therapeutic protection against the development of Ebola virus disease (EVD) in infected nonhuman primates Late Ebola virus relapse causing meningoencephalitis: a case report A randomized, controlled trial of Ebola virus disease therapeutics Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Learning from the past: possible urgent prevention and treatment options for severe Acute respiratory infections caused by 2019-nCoV First case of 2019 novel coronavirus in the United States Mild/moderate 2019-nCoV remdesivir RCT -Full Text View -ClinicalTrials Severe 2019-nCoV remdesivir RCT -Full Text View -ClinicalTrials Al-Tawfiq * Infectious Disease Unit, Specialty Internal Medicine and Infection Control Unit, Quality and Patient Safety [3] as well as in a rhesus monkey model of Ebola virus disease [4] .	cache/cord-254717-1hwdd7nq.txt	txt/cord-254717-1hwdd7nq.txt
